MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
ROCKVILLE, Md., March 11, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT;…
US Metro Bancorp Declares Interim Dividend on Common Stock
GARDEN GROVE, Calif.--(BUSINESS WIRE)--US Metro Bancorp (OTCQX: USMT) declared that its Board…
Viemed Healthcare Announces Record 2024 Financial Results
LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the…
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”)…
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth:…
zSpace Announces Date Change for its Conference Call to Discuss Fourth Quarter and Full Year 2024 Results
March 07, 2025 16:05 ET | Source: zSpace, Inc. SAN JOSE, Calif.,…
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting
- Full data from the Phase 3 TRuE-PN1 study, presented today in…
AppTech Payments Corp. Highlights Q4 2024 Financial and Strategic Developments
CARLSBAD, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech…
Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET
March 07, 2025 17:30 ET | Source: Better Choice Company Inc. TAMPA,…